Cargando…
MEDB-40. RUNNING FOR INCLUSION IN SIOPE PNET5 MB
Enrolling medulloblastoma(MB) patients in the PNET5 protocol is a daily problem in Italy; since June 2015, 59 cases have been enrolled in 13 centres. So far, 44 of the 103 patients claiming for eligibility did not enter the protocol: 13 metastases, 5 for residual, 20 having exclusion criteria, 4 ins...
Autores principales: | Massimino, Maura, Boschetti, Luna, Minasi, Simone, Erbetta, Alessandra, Chiapparini, Luisa, Mastronuzzi, Angela, Miele, Evelina, Barra, Salvina, Scarzello, Giovanni, Cavatorta, Claudia, Antonelli, Manila, Gandola, Lorenza, Buttarelli, Francesca Romana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164657/ http://dx.doi.org/10.1093/neuonc/noac079.414 |
Ejemplares similares
-
MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy
por: Garrè, Maria Luisa, et al.
Publicado: (2022) -
MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
por: Buttarelli, Francesca Romana, et al.
Publicado: (2022) -
MEDB-75. Treatment-induced pulmonary toxicity in patients with medulloblastoma: a retrospective analysis on 2 Italian institutions’ cohorts
por: Biassoni, Veronica, et al.
Publicado: (2022) -
MEDB-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells
por: Spinello, Zaira, et al.
Publicado: (2022) -
MEDB-46. ONC201 affects Group 3 Medulloblastoma growth by impairing cancer stem cells
por: Abballe, Luana, et al.
Publicado: (2022)